US

Theodore L Iorio

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodore L Iorio. Retrieved from https://idiyas.com/inventor/theodore-l-iorio-tbej079y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovative Contributions of Theodore L. Iorio

Introduction

Theodore L. Iorio is an accomplished inventor known for his work in the pharmaceutical field. He has developed innovative formulations aimed at improving cardiovascular health. His contributions are particularly significant for individuals at elevated cardiovascular risk.

Latest Patents

The most notable patent attributed to Theodore L. Iorio is the "Combination Dosage Form Containing A Cholesterol-Lowering Agent, A Renin-Angiotensin Inhibitor, And Aspirin." This orally administrable pharmaceutical formulation combines a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin. The formulation is designed for once-daily dosing and aims to reduce the risk of cardiovascular events, especially in individuals with systemic lupus erythematosus or those experiencing acute myocardial infarction.

Career Highlights

Throughout his career, Theodore L. Iorio has made significant strides in the pharmaceutical industry. He has worked with various companies, including Shubha Chungi and Theodore L. Iorio, where he has contributed to the development of innovative health solutions. His work has been instrumental in addressing critical health issues related to cardiovascular diseases.

Collaborations

Theodore L. Iorio has collaborated with Shubha Chungi, enhancing the impact of his inventions through teamwork and shared expertise. Their partnership has led to advancements in pharmaceutical formulations that benefit patients.

Conclusion

Theodore L. Iorio's innovative contributions to the field of pharmaceuticals demonstrate his commitment to improving health outcomes. His work, particularly in cardiovascular health, showcases the importance of combining various therapeutic agents for enhanced efficacy. His legacy continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…